Related references
Note: Only part of the references are listed.International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Immunoadsorption Therapy for Neuromyelitis Optica Spectrum Disorders Long After the Acute Phase
Masatake Kobayashi et al.
JOURNAL OF CLINICAL APHERESIS (2015)
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
Corinna Trebst et al.
JOURNAL OF NEUROLOGY (2014)
Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies - Perspectives for immunoadsorption
Reinhard Klingel et al.
ATHEROSCLEROSIS SUPPLEMENTS (2013)
Efficacy and safety of beta-interferon in Thai patients with demyelinating diseases
B. Jarernsook et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Therapeutic apheresis for autoimmune encephalitis. A nationwide data collection
S. Ehrlich et al.
NERVENARZT (2013)
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
Ju-Hong Min et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Therapeutic efficacy of double filtration plasmapheresis in patients with anti-aquaporin-4 antibody-positive multiple sclerosis
Masashi Munemoto et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Intermittent Plasmapheresis Prevents Recurrence in Neuromyelitis Optica
Katsuichi Miyamoto et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2009)
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
VA Lennon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Share Paper
